These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33079302)

  • 1. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis.
    Urrego-Callejas T; Álvarez SS; Arias LF; Reyes BO; Vanegas-García AL; González LA; Muñoz-Vahos CH; Vásquez G; Quintana LF; Gómez-Puerta JA
    Clin Rheumatol; 2021 May; 40(5):1853-1859. PubMed ID: 33079302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
    Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.
    Brunner HI; Bennett MR; Mina R; Suzuki M; Petri M; Kiani AN; Pendl J; Witte D; Ying J; Rovin BH; Devarajan P
    Arthritis Rheum; 2012 Aug; 64(8):2687-97. PubMed ID: 22328173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
    Davies JC; Carlsson E; Midgley A; Smith EMD; Bruce IN; Beresford MW; Hedrich CM;
    Rheumatology (Oxford); 2021 Aug; 60(8):3747-3759. PubMed ID: 33313921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
    Bennett MR; Ma Q; Ying J; Devarajan P; Brunner H
    Pediatr Rheumatol Online J; 2017 Oct; 15(1):74. PubMed ID: 29029629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    Brunner HI; Bennett MR; Gulati G; Abulaban K; Klein-Gitelman MS; Ardoin SP; Tucker LB; Rouster-Stevens KA; Witte D; Ying J; Devarajan P
    J Rheumatol; 2017 Aug; 44(8):1239-1248. PubMed ID: 28620062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
    Guimarães JAR; Furtado SDC; Lucas ACDS; Mori B; Barcellos JFM
    PLoS One; 2022; 17(10):e0275016. PubMed ID: 36215243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis.
    Soliman S; Mohamed FA; Ismail FM; Stanley S; Saxena R; Mohan C
    Int J Rheum Dis; 2017 Nov; 20(11):1714-1727. PubMed ID: 29076253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
    Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
    J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.
    Xuejing Z; Jiazhen T; Jun L; Xiangqing X; Shuguang Y; Fuyou L
    J Biomed Biotechnol; 2012; 2012():359647. PubMed ID: 22719208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis.
    El-Shehaby A; Darweesh H; El-Khatib M; Momtaz M; Marzouk S; El-Shaarawy N; Emad Y
    J Clin Immunol; 2011 Oct; 31(5):848-56. PubMed ID: 21691937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    Ngamjanyaporn P; Worawichawong S; Pisitkun P; Khiewngam K; Kantachuvesiri S; Nongnuch A; Assanatham M; Sathirapongsasuti N; Kitiyakara C
    PLoS One; 2022; 17(3):e0263778. PubMed ID: 35271583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
    Moloi MW; Rusch JA; Omar F; Ekrikpo U; Dandara C; Bello AK; Jayne D; Okpechi IG
    Int Urol Nephrol; 2021 Sep; 53(9):1865-1873. PubMed ID: 33459955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.